Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension Review article

Article Sidebar

Requires Subscription PDF (Język Polski)


Published: Mar 31, 2009
Keywords:
hypertension, combined treatment, ACE inhibitor, calcium antagonist

Main Article Content

Piotr Jędrusik
Katedra i Klinika Chorób Wewnętrznych, Nadciśnienia Tętniczego i Angiologii WUM

Abstract

The ACCOMPLISH study compared combined treatment with benazepril-amlodypine and benazepril-hydrochlorthiazide in hypertensive patients at high risk of cardiovascular events. The use of benazepril-amlodipine combination resulted in reduced cardiovascular morbidity and mortality compared to treatment with benazepril and hydrochlorthiazide despite similar blood pressure reduction in both study groups.

Downloads

Download data is not yet available.

Article Details

How to Cite
Jędrusik , P. (2009). Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension. Cardiology in Practice, 3(1), 23-25. Retrieved from https://journalsmededu.pl/index.php/kwp/article/view/1667
Issue
Vol 3 No 1 (2009)
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Jamerson K., Weber M.A., Bakris G.L. et al.: Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N. Engl. J. Med. 2008, 359: 2417-2428.
2. Chobanian A.V.: Does it matter how hypertension is controlled? N. Engl. J. Med. 2008, 359: 2485-88.
3. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288: 2981-2997.